Comments
Pursuant to provisions of Regulation 30 and 33 and any other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015,(hereinafter SEBI Listing Regulations, this is to inform that the Board of Directors of the Company in its meeting held today, i.e. 22nd day of May, 2019 have inter- alia considered, approved and taken on record the followings:- The audited standalone financial results along with Statement of Assets & Liabilities of the Company for the fourth quarter(Q4) and financial year ended 31st March, 2019, which was recommended by the Audit Committee at their meeting held on May 22nd, 2019, copies whereof alongwith audit report for standalone results and declaration by the Chief Financial Officer of the Company in terms of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pdf Link: Brawn Biotech Ltd. - Results-Financial Year For The Financial Year Ending 31St March,2019.
Source : BSE - www.bseindia.com
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.